Portman Square Capital LLP Enovis Corp Transaction History
Portman Square Capital LLP
- $2.47 Billion
- Q3 2024
A detailed history of Portman Square Capital LLP transactions in Enovis Corp stock. As of the latest transaction made, Portman Square Capital LLP holds 404,700 shares of ENOV stock, worth $19.4 Million. This represents 0.71% of its overall portfolio holdings.
Number of Shares
404,700
Previous 10,683
3688.26%
Holding current value
$19.4 Million
Previous $482,000
3514.52%
% of portfolio
0.71%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding ENOV
# of Institutions
301Shares Held
59.9MCall Options Held
1.63MPut Options Held
576K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.64MShares$319 Million0.19% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$261 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.35MShares$257 Million0.0% of portfolio
-
Diamond Hill Capital Management Inc Columbus, OH3MShares$144 Million0.54% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.99MShares$144 Million0.03% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $2.6B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...